Clinical Trial Update: Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis [NA]

View source ↗

Summary

The trial evaluating the probiotic VSL#3 as an adjunct to standard therapy for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VSL#3

Snippet

Sponsor: VSL Pharmaceuticals | Conditions: Ulcerative Colitis | NA | Status: COMPLETED